13 articles for thisTarget

---

The following articles (labelled with PubMed ID or TBD) are for your review

PMID	Data	Article Title	Organization
24900651	50	Irreversible inhibitors of cysteine proteases.	Dart Neuroscience
19715320	87	Grassystatins A-C from marine cyanobacteria, potent cathepsin E inhibitors that reduce antigen presentation.	University of Florida
18366176	7	Identification of promiscuous small molecule activators in high-throughput enzyme activation screens.	University of Illinois
21903398	88	Exploiting differences in caspase-2 and -3 S2 subsites for selectivity: structure-based design, solid-phase synthesis and in vitro activity of novel substrate-based caspase-2 inhibitors.	Chdi Management
17181147	10	Synthesis of novel caspase inhibitors for characterization of the active caspase proteome in vitro and in vivo.	University of Edinburgh
15686936	210	Novel pyrazinone mono-amides as potent and reversible caspase-3 inhibitors.	Merck Frosst Centre For Therapeutic Research
27563406	128	Discovery of Fluoromethylketone-Based Peptidomimetics as Covalent ATG4B (Autophagin-1) Inhibitors.	Roche Pharma Research and Early Development
28615111	24	Synthesis and antitumor activities of 1,2,3-triazines and their benzo- and heterofused derivatives.	Universit£
18308563	39	Probing the elusive catalytic activity of vertebrate class IIa histone deacetylases.	Irbm/Merck Research Laboratories
17685602	33	Discovery of 3,3'-(2,4-diaminopteridine-6,7-diyl)diphenol as an isozyme-selective inhibitor of PI3K for the treatment of ischemia reperfusion injury associated with myocardial infarction.	Targegen
14698155	68	Synthesis and evaluation of indenopyrazoles as cyclin-dependent kinase inhibitors. Part 4: Heterocycles at C3.	Bristol-Myers Squibb